SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,640.00    -10.00 (-0.18%)
Bid:
5,640.00
Ask:
5,670.00
Spread: 30.00 (0.532%)
Market Cap: £3.02b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Half Year Trading Update

27 Sep 2024 07:00

RNS Number : 8990F
Cranswick PLC
27 September 2024
Β 

27 September 2024

Β 

Cranswick plc

("Cranswick" or "the Company" or "the Group")

Β 

Β 

Half year trading update

Β 

Cranswick, a leading UK food producer, today provides an update on trading for the 26 weeks to 28 September 2024.

Β 

Current trading

Trading since the end of the first quarter has been stronger than previously expected, underpinned by continued robust volume growth in our core UK food business, a positive ongoing contribution from our expanding pig farming operations, industry leading service levels and a relentless focus on quality and innovation. Consequently, we now expect our first half performance to be ahead of the same period last year.

Β 

Investment in our asset base continues at pace with the new houmous facility in Worsley, Manchester successfully commissioned during the period.

Β 

Outlook

Whilst we remain cautious about current market and wider economic and geopolitical conditions, following the strong volume growth delivered through the first half, our outlook for the current financial year ending 29 March 2025 is now expected to be towards the upper end of current market expectations1.

Β 

The Board remains confident that continued focus on the strengths of the Company, which include its long-standing customer relationships, breadth and quality of products and industry leading asset infrastructure, will support the further successful development of the Group over the longer term.

Β 

Interim results

The Company's next scheduled comment on trading will be the interim results announcement on Tuesday 26 November 2024.

Β 

Β 

Enquiries:

Β 

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Sodali & Co

+44 207 100 6451

Ben Foster / Louisa Henry

cranswick@sodali.com

Β 

Notes:

Β 

1. Market expectations for adjusted profit before tax as at 27 September 2024 ranged between Β£179.2m and Β£191.7m.

2. Cranswick is a leading and innovative supplier of premium, fresh and added-value food products. The business employs over 15,000 people and operates from 23 well-invested, highly efficient production facilities in the UK. Cranswick was formed in the early 1970s by farmers in East Yorkshire to produce animal feed and has since evolved into a business which produces a range of high quality, predominantly fresh food, including fresh pork, poultry, convenience, gourmet products and pet food. The business develops innovative, great tasting food products to the highest standards of food safety and traceability. The Group supplies the major grocery multiples as well as the growing premium and discounter retail channels. Cranswick also has a strong presence in the 'food-to-go' sector and a substantial export business. Results for the 53 weeks to 30 March 2024 showed revenue of Β£2,599.3m and profit before tax of Β£158.4m. For more information go to: www.cranswick.plc.uk

3. At Cranswick, it is second nature for us to protect and nurture our environment while supporting people and communities to thrive. Guided by our sustainability strategy, Second Nature, we have seamlessly integrated our sustainability commitments into the core of our business model, which in turn shapes our decision-making, culture, and actions. For more information on out Second Nature strategy, please visit: www.cranswick.plc.uk/sustainability

4. This announcement is based on information sourced from unaudited management accounts.

5. This announcement contains certain forward looking statements. By their nature, forward looking statements involve a number of risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. Forward looking statements regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. Accordingly undue reliance should not be placed on forward looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTZZGZLLVLGDZM
Date   Source Headline
14th Jul 20163:13 pmRNSHolding(s) in Company
7th Jul 20164:27 pmRNSDividend Declaration
1st Jul 20163:23 pmRNSDirector/PDMR Shareholding
1st Jul 20169:17 amRNSTotal Voting Rights
21st Jun 20164:51 pmRNSDirector/PDMR Shareholding
6th Jun 20162:09 pmRNSTotal Voting Rights
26th May 20169:14 amRNSDirector Declaration
24th May 20167:00 amRNSFinal Results
18th May 20163:14 pmRNSHolding(s) in Company
4th May 20169:23 amRNSAdditional Listing
11th Apr 20167:00 amRNSAcquisition of leading integrated poultry business
5th Apr 20167:00 amRNSTrading Statement
1st Apr 20164:53 pmRNSBlocklisting Interim Review
1st Apr 20164:47 pmRNSBlocklisting Interim Review
1st Apr 201611:23 amRNSTotal Voting Rights
18th Mar 20164:44 pmRNSDirector/PDMR Shareholding
18th Mar 20164:22 pmRNSDirector/PDMR Shareholding
2nd Mar 20164:30 pmRNSDirector/PDMR Shareholding
26th Feb 20163:04 pmRNSDirector/PDMR Shareholding
26th Feb 201610:08 amRNSDirector Declaration
2nd Feb 20169:23 amRNSDirector/PDMR Shareholding
1st Feb 201611:45 amRNSDirector/PDMR Shareholding
1st Feb 201611:44 amRNSDirector/PDMR Shareholding
28th Jan 20167:00 amRNSTrading Statement
27th Jan 201611:44 amRNSAdditional Listing
17th Dec 20152:44 pmRNSDividend Declaration
14th Dec 20155:38 pmRNSDirector/PDMR Shareholding
30th Nov 20157:00 amRNSHalf Yearly Report
5th Oct 201510:38 amRNSBlocklisting Interim Review
5th Oct 201510:37 amRNSBlocklisting Interim Review
1st Oct 20154:13 pmRNSTotal Voting Rights
1st Oct 20157:00 amRNSFirst Half Trading Statement
28th Sep 201511:03 amRNSDirector Declaration
8th Sep 20154:56 pmRNSDirector/PDMR Shareholding
8th Sep 20154:53 pmRNSDirector/PDMR Shareholding
8th Sep 20154:51 pmRNSDirector/PDMR Shareholding
1st Sep 20151:45 pmRNSAdditional Listing
10th Aug 20154:06 pmRNSDirector/PDMR Shareholding
5th Aug 20154:18 pmRNSTR-1: Notification of Major Interest in Shares
3rd Aug 20156:19 pmRNSTotal Voting Rights
28th Jul 201511:56 amRNSResult of AGM
27th Jul 20157:00 amRNSInterim Management Statement
13th Jul 20156:17 pmRNSDividend Declaration
15th Jun 20155:47 pmRNSDirector/PDMR Shareholding
4th Jun 20158:21 amRNSTotal Voting Rights
19th May 20157:00 amRNSDirector Declaration
18th May 20157:00 amRNSFinal Results
9th Apr 20157:00 amRNSFourth Quarter Trading Statement
7th Apr 20159:22 amRNSBlocklisting Interim Review
7th Apr 20159:18 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.